Medical therapy is an established first-line approach for the treatment of patients with chronic anal fissure; however, the efficacy of individual agents versus placebo remains to be proven in this ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Acrux Limited has announced the ...
October 21, 2010 (Toronto, Ontario) — Nitroglycerin applied topically increases bone formation and reduces bone resorption in women with osteopenia, and it might prove to be an effective and ...
Apurva Saraf, President and CEO of Cosette Pharma, stated, "This is a pivotal product approval, and a testament to our unwavering dedication to R&D, operational excellence and innovation. This is ...
Three of four authors have retracted the JAMA article, "Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women: A Randomized Trial." The article was published in ...
Acrux Limited (AU:ACR) has released an update. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify ...
NEW YORK (CBS.MW) -- Shares of Cellegy Pharmaceuticals saw their value cut almost in half Monday after the company suffered a setback in its bid to win U.S. marketing approval for Cellegesic, its ...
Treatment with low doses of transdermal nitroglycerin has no effect on postmenopausal BMD, according to investigators. Menopause, and its inherent decrease of estrogen levels, is one of the leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results